Miranda B. Bennink - Concepedia

Author

Miranda B. Bennink

Radboud University Medical Center

Also Known As

Miranda B Bennink, Miranda B. Bennink, Miranda Bennink

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Radboud University Medical Center Radboud University Nijmegen Radboud Institute for Molecular Life Sciences McMaster University

About

Miranda B. Bennink is an author at Radboud University Medical Center specializing in medicine, immunology, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	605
2	Biochemistry	2	2	122
3	Engineering	1	1	42
4	Allergy	1	1	92
5	Biomedical Engineering	1	1	42

Miranda B. Bennink

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models Onno J. Arntz, Bartijn C. H. Pieters, Marina C. Oliveira, Molecular Nutrition & Food Research	2015	259
Commercial Cow Milk Contains Physically Stable Extracellular Vesicles Expressing Immunoregulatory TGF-β Bartijn C. H. Pieters, Onno J. Arntz, Miranda B. Bennink, PLoS ONE	2015	208
Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging Alfons S.K. de Hooge, Fons A. J. van de Loo, Miranda B. Bennink, Osteoarthritis and Cartilage InflammationRheumatologyMusculoskeletal ResearchAdvanced OsteoarthritisImmunology	2004	160
Local activation of STAT‐1 and STAT‐3 in the inflamed synovium during zymosan‐induced arthritis: Exacerbation of joint inflammation in STAT‐1 gene–knockout mice Alfons S.K. de Hooge, Fons A. J. van de Loo, Marije I. Koenders, Arthritis & Rheumatism	2004	110
Deficiency of NADPH Oxidase Components p47phox and gp91phox Caused Granulomatous Synovitis and Increased Connective Tissue Destruction in Experimental Arthritis Models Fons A. J. van de Loo, Miranda B. Bennink, Onno J. Arntz, American Journal Of Pathology InflammationRheumatologyRheumatoid DisorderMusculoskeletal ResearchAutoimmune Disease	2003	96
Disease-Regulated Gene Therapy with Anti-Inflammatory Interleukin-10 Under the Control of the CXCL10 Promoter for the Treatment of Rheumatoid Arthritis Mathijs G A Broeren, Marieke de Vries, Miranda B. Bennink, Human Gene Therapy ImmunologyImmune RegulationPathologyBiological TherapyInnate Immunity	2015	92
Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models Claire E. J. Waterborg, Silke Beermann, Mathijs G A Broeren, Frontiers in Immunology	2018	67
Tetraspanin CD37 protects against the development of B cell lymphoma Charlotte M. de Winde, Sharon Veenbergen, Ken H. Young, Journal of Clinical Investigation Lymphoid NeoplasiaLymphocyte DevelopmentLymphoma DevelopmentMalignant Blood DisorderImmunology	2016	59
Adenoviral Transfer of Murine Oncostatin M Elicits Periosteal Bone Apposition in Knee Joints of Mice, Despite Synovial Inflammation and Up-Regulated Expression of Interleukin-6 and Receptor Activator of Nuclear Factor-κB Ligand Alfons S.K. de Hooge, Fons A. J. van de Loo, Miranda B. Bennink, American Journal Of Pathology InflammationRheumatologyNuclear Factor-κb LigandAnti-inflammatoryImmunology	2002	56
Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis Annemarie van Nieuwenhuijze, Fons AJ van de Loo, Birgitte Walgreen, Arthritis Research & Therapy ImmunologyImmune RegulationPathologyComplementary ActionImmune System	2015	48

Page 1